Tanaka Hiroyuki
Department of Pediatrics, Okayama Saiseikai General Hospital.
Clin Calcium. 2010 Oct;20(10):1490-6.
FGFR3 has been establishing its position in growth plate cartilage after the identification as a responsible gene for achondroplasia. The major pathway of the pathogenesis in achondroplasia is the suppression of PTHrP-PTHR system, which is mainly mediated by ERK activation induced by constitutive active FGFR3. However, intracellular signaling system in FGFR3 is complex and the molecular pathogenesis of achondroplasia and related disorders has not been fully clarified. Especially, recently found human loss-of-function mutations in newly identified syndromes casted novel findings in the relation between phenotype and receptor function. In this review, I summarized recent consensus in the pathogenesis of FGFR3 related chondrodysplasia.
在被确定为软骨发育不全的致病基因后,FGFR3在生长板软骨中确立了其地位。软骨发育不全发病机制的主要途径是PTHrP-PTHR系统的抑制,这主要由组成型活性FGFR3诱导的ERK激活介导。然而,FGFR3的细胞内信号系统很复杂,软骨发育不全及相关疾病的分子发病机制尚未完全阐明。特别是,最近在新发现的综合征中发现的人类功能丧失突变在表型与受体功能之间的关系方面带来了新的发现。在这篇综述中,我总结了FGFR3相关软骨发育异常发病机制的最新共识。